Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Strategies to overcome/penetrate the BBB for systemic nanoparticle delivery to the brain/brain tumor

Advanced Drug Delivery Reviews(2022)10.1016/j.addr.2022.114619Source: DataRank Database

Strategies to overcome/penetrate the BBB for systemic nanoparticle delivery to the brain/brain tumor is a research paper published in Advanced Drug Delivery Reviews (2022). On theSindex it has a DataRank of 0. It has been cited 117 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access117 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)OA: greenTopics (20)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Peisheng Xu ORCID,Haijun Liu ORCID

Live enrichment

PubMed:36372301 PMC:PMC9724744

National Institutes of Health

Grant: 1R01AG054839-01A1

Brain targeted nanoparticle for Alzheimer's disease therapy

National Institutes of Health

Grant: 1R01CA263747-01A1

Cancer cell selective killing nanoparticle for advanced ovarian cancer treatment

National Institutes of Health

Grant: 1R21CA252360-01

Nanoparticle delivered miR-489 rejuvenates anthracycline-based chemotherapy

National Institutes of Health

Grant: 1R41CA254500-01A1

A novel polymer-metal nanocomplex for ovarian cancer treatment

NIA NIH HHS

Grant: R01 AG054839

NCI NIH HHS

Grant: R01 CA263747

NCI NIH HHS

Grant: R21 CA252360

NCI NIH HHS

Grant: R41 CA254500

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9724744

publisherhttps://api.elsevier.com/content/article/PII:S0169409X22005099?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0169409X22005099?httpAccept=text/plain

https://doi.org/10.1016/j.addr.2022.114619

https://pubmed.ncbi.nlm.nih.gov/36372301

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Blood-Brain BarrierHumansBrain NeoplasmsDrug Delivery SystemsNanomedicineNanoparticlesTranscytosis

Keywords

TransportNanoparticleBrain tumorBlood-Brain BarriertranscytosisNanomedicineDrug Delivery SystemsBrain NeoplasmsHumansNanoparticles

Sustainable Development Goals

SDG 3: 3. Good health

Related Papers (10)

Dual Role of WISP1 in maintaining glioma stem cells and tumor-supportive macrophages in glioblastoma

N/A

0.781DataRank · unranked

Nature Communications(2020)

co-cited

10.1038/s41467-020-16827-z

Cell-surface antigen profiling of pediatric brain tumors: B7-H3 is consistently expressed and can be targeted via local or systemic CAR T-cell delivery

Neuro-Oncology(2020)

co-cited

10.1093/neuonc/noaa278

Targeting PAK4 to reprogram the vascular microenvironment and improve CAR-T immunotherapy for glioblastoma

N/A

0.745DataRank · unranked

Nature Cancer(2020)

co-cited

10.1038/s43018-020-00147-8

SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastoma

Science Translational Medicine(2021)

co-cited

10.1126/scitranslmed.abe7378

Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cells

Journal of Clinical Investigation(2021)

co-cited

10.1172/jci142116

Breaking barriers: Neurodegenerative repercussions of radiotherapy induced damage on the blood-brain and blood-tumor barrier

Free Radical Biology and Medicine(2021)

co-cited

10.1016/j.freeradbiomed.2021.12.002

PIK3CA mutations in plasma circulating tumor DNA predict survival and treatment outcomes in patients with advanced cancers

ESMO Open(2021)

co-cited

10.1016/j.esmoop.2021.100230

RASA2 ablation in T cells boosts antigen sensitivity and long-term function

Nature(2022)

co-cited

10.1038/s41586-022-05126-w

Off-the-shelf, steroid-resistant, IL13Rα2-specific CAR T cells for treatment of glioblastoma

Neuro-Oncology(2022)

co-cited

10.1093/neuonc/noac024

Lactate limits CNS autoimmunity by stabilizing HIF-1α in dendritic cells

Nature(2023)

co-cited

10.1038/s41586-023-06409-6